Qiagen and Luminex Agree to Jointly Develop Lab Assays | GenomeWeb

NEW YORK, Nov 27 – Qiagen and Luminex have agreed to jointly develop consumable kits and assays using Luminex’s Labmap technology, the companies announced Monday.

Under the agreement, Qiagen will market the assay detection products beginning in the third quarter of 2001. Luminex has received an upfront payment for the Labmap technology, and will receive future royalty payments from Qiagen based on the sale of kits and reagents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.